| 000 | 01839 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250514204741.0 | ||
| 264 | 0 | _c20041207 | |
| 008 | 200412s 0 0 eng d | ||
| 022 | _a0007-0920 | ||
| 024 | 7 |
_a10.1038/sj.bjc.6602156 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMyers, E | |
| 245 | 0 | 0 |
_aInverse relationship between ER-beta and SRC-1 predicts outcome in endocrine-resistant breast cancer. _h[electronic resource] |
| 260 |
_bBritish journal of cancer _cNov 2004 |
||
| 300 |
_a1687-93 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Hormonal _xpharmacology |
| 650 | 0 | 4 | _aBlotting, Western |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 |
_aEstradiol _xpharmacology |
| 650 | 0 | 4 |
_aEstrogen Receptor alpha _xmetabolism |
| 650 | 0 | 4 |
_aEstrogen Receptor beta _xmetabolism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFluorescent Antibody Technique |
| 650 | 0 | 4 | _aHistone Acetyltransferases |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunoenzyme Techniques |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasms, Hormone-Dependent _xdrug therapy |
| 650 | 0 | 4 | _aNuclear Receptor Coactivator 1 |
| 650 | 0 | 4 |
_aReceptor, ErbB-2 _xmetabolism |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 |
_aTamoxifen _xpharmacology |
| 650 | 0 | 4 |
_aTranscription Factors _xmetabolism |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aFleming, F J | |
| 700 | 1 | _aCrotty, T B | |
| 700 | 1 | _aKelly, G | |
| 700 | 1 | _aMcDermott, E W | |
| 700 | 1 | _aO'higgins, N J | |
| 700 | 1 | _aHill, A D K | |
| 700 | 1 | _aYoung, L S | |
| 773 | 0 |
_tBritish journal of cancer _gvol. 91 _gno. 9 _gp. 1687-93 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.bjc.6602156 _zAvailable from publisher's website |
| 999 |
_c15169006 _d15169006 |
||